239 filings
Page 5 of 12
8-K
5e7qetug6
27 Mar 20
Other Events
5:17pm
8-K
muagwny
18 Mar 20
Entry into a Material Definitive Agreement
9:24pm
UPLOAD
v9vb6g5wyaxahov6
10 Jan 20
Letter from SEC
12:00am
8-K
z6jy5tjf
8 Jan 20
Entry into a Material Definitive Agreement
2:26pm
CORRESP
g5doe9ndclr6tkuw1r
23 Dec 19
Correspondence with SEC
12:00am
8-K
pnynvgmdll
17 Dec 19
Entry into a Material Definitive Agreement
12:00am
424B5
veqqp 5gedw
17 Dec 19
Prospectus supplement for primary offering
12:00am
UPLOAD
m9291odd61uvfre63
25 Nov 19
Letter from SEC
12:00am
CORRESP
dbzdtpv nbp
29 Oct 19
Correspondence with SEC
12:00am
UPLOAD
g6hf2lp00ac03hji1
23 Oct 19
Letter from SEC
12:00am
8-K
b6w2v0kex
9 Jul 19
Axim® Biotechnologies Signs Licensing Agreement with Leading Gum Distributor to Expand Nutraceutical Division
3:39pm
8-K
s4soix
4 Jun 19
AXIM® Biotechnologies, Inc. Signs Cannabinoid Product Supply Agreement with Healthcare Company for Clinical Trials on Treatment of Periodontitis
12:00am
8-K
reye5febzt1e46jvvo5a
23 Apr 19
AXIM® Biotechnologies, Inc. Nutraceutical Division Receives Purchase Order for 50,000 Boxes of the Company’s Proprietary CBD-Based Chewing Gum
4:58pm
8-K
ingzf9d38 w0s949oo
4 Apr 19
AXIM® Biotechnologies, Inc. Appoints Mauricio Javier Gatto-Bellora to Company’s Board of Directors
12:07pm
NT 10-K
j438o3z2caw
29 Mar 19
Notice of late annual filing
8:18pm